Literature DB >> 15648108

Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection.

In-Kyu Park1, Hu-Lin Jiang, Seung-Eun Cook, Myung-Haing Cho, Su-Il Kim, Hwan-Jeong Jeong, Toshihiro Akaike, Chong-Su Cho.   

Abstract

Galactosylated chitosan-graft-poly(vinyl pyrrolidone) (GCPVP) was synthesized and characterized for hepatocyte-targeting gene carrier. GCPVP itself as well as GCPVP/DNA complex had negligible cytotoxicity regardless of the concentration of GCPVP and the charge ratio, but GCPVP/DNA complex had slightly cytotoxic effect on HepG2 cells only in the case of the higher charge ratio and 20 mM of Ca2+ concentration used. Through the confocal laser scanning microscopy, it is shown that the endocytosis by interaction between galactose ligands of GCPVP and ASGPR of the hepatocytes was the major route of transfection of GCPVP/F-plasmid complexes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648108     DOI: 10.1007/BF02975895

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

Review 1.  Carbohydrate polymers for nonviral nucleic acid delivery.

Authors:  Antons Sizovs; Patrick M McLendon; Sathya Srinivasachari; Theresa M Reineke
Journal:  Top Curr Chem       Date:  2010

Review 2.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

3.  Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo.

Authors:  Yan Xiao; Huafang Zhang; Zhaoguo Zhang; Mina Yan; Ming Lei; Ke Zeng; Chunshun Zhao
Journal:  Int J Nanomedicine       Date:  2013-08-12

4.  Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.

Authors:  Gyati Shilakari Asthana; Abhay Asthana; Dharm Veer Kohli; Suresh Prasad Vyas
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.